Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOME II bosentan study in systemic sclerosis with early or active nailfold capillaroscopic pattern
NL-OMON39115Phase 4Recruiting
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bosentan in systemic sclerosis (SSc), sponsored by Actelion Pharmaceuticals Ltd. Started Mar 2012; status: recruiting.
02
Drugs
bosentan
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NL-OMON39115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39115.